Drug Trial Radar · NCT01928888
Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes
Last checked: Nov 19, 2026Latest source record: Dec 25, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
559
Actual
Start
May 2003
Primary completion
Feb 2004
Study completion Feb 2004
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Aug 27, 2013
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy and safety of a single oral administration of 1000 mg Talcid® (study medication), a single oral administration of 10 mg famotidine and a single oral administration of placebo (comparator without an active substance) in treating the symptoms of acute heartburn episodes. The study is designed to collect more efficacy data on Talcid® in patients using self-medication to relief the symptoms of acute heartburn.
Conditions
- Heartburn
Interventions
Talcid (Hydrotalcite, BAY4516H)Drug
2 tablets hydrotalcite (2x500mg) 1000mg and 1 capsule placebo to famotidine
FamotidineDrug
2 tablets placebo to hydrotalcite and 1 capsule famotidine 10 mg
PlaceboDrug
2 tablets placebo to hydrotalcite and 1 capsule placebo to famotidine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total heartburn relief over 0-60 minTime frame: up to 60 minutes
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Ask Central Contact, Germany
Site not named
Frankfurt am Main, Hesse, Germany
Site not named
Dresden, Saxony, Germany
Site not named
Leipzig, Saxony, Germany
Site not named
Berlin, State of Berlin, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.